Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? - Ayr...

Javier Gasse
Fri, Nov 29
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Discover